NCT07457177 2026-03-09
Phaes â…¡ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL
Beijing Tongren Hospital
Phase 2 Not yet recruiting
Clinical Trials
18 trialsNCT06069830 2026-01-27
ENKTL
Ruijin Hospital
Phase NA Recruiting
NCT04509466 2024-03-07
Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2 Terminated
NCT05254899 2022-02-24
Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL
ChineseAMS
Phase 2 Unknown
NCT02733458 2021-09-14
GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Completed
NCT02631239 2021-08-25
MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma
Ruijin Hospital
Phase 3 Unknown
NCT04917250 2021-06-08
GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma
Beijing Tongren Hospital
Phase 2 Unknown
NCT04899414 2021-05-24
Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell Lymphoma
Peking University
Phase 2 Unknown
NCT02085655 2021-03-15
PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma
Sun Yat-sen University
Phase 3 Unknown
NCT04676789 2020-12-21
SPENT
Sun Yat-sen University
Phase 2 Unknown
NCT04405375 2020-05-28
GPED Regimen for Relapsed/Refractory or Advanced ENKTCL
Beijing Tongren Hospital
Phase 2 Unknown
NCT02359162 2018-05-09
Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage
Sun Yat-sen University
Phase 3 Terminated
NCT02533323 2018-05-09
P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens
Sun Yat-sen University
Phase 2 Terminated
NCT02825147 2017-11-14
Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma
Ruijin Hospital
Phase 2 Completed
NCT01991158 2016-06-14
GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma
Sun Yat-sen University
Phase 2 Unknown
NCT02080234 2016-04-20
Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL
Sun Yat-sen University
Phase 2 Unknown
NCT01921790 2013-08-22
Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma
Sun Yat-sen University
Phase 2 Unknown
NCT01667302 2013-03-05
Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma
Fudan University
Phase 2 Unknown